Compare BBNX & ETB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BBNX | ETB |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | 423 | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 493.1M | 448.6M |
| IPO Year | N/A | 2004 |
| Metric | BBNX | ETB |
|---|---|---|
| Price | $14.61 | $15.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $23.80 | N/A |
| AVG Volume (30 Days) | ★ 780.1K | 48.1K |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $34.90 | N/A |
| Revenue Next Year | $34.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.80 | $13.86 |
| 52 Week High | $32.71 | $15.67 |
| Indicator | BBNX | ETB |
|---|---|---|
| Relative Strength Index (RSI) | 71.48 | 39.66 |
| Support Level | $9.34 | $14.87 |
| Resistance Level | $15.53 | $15.17 |
| Average True Range (ATR) | 0.96 | 0.18 |
| MACD | 0.27 | -0.06 |
| Stochastic Oscillator | 91.73 | 20.42 |
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Eaton Vance Tax-Managed Buy-Write Income Fund is a United States-based diversified closed ended management investment company. The fund's investment objective is to provide current income and gains, with a secondary objective of capital appreciation. It invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of aerospace and defense, banks, biotechnology, chemicals, consumer finance, industrial conglomerates, and others.